Cite
Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice.
MLA
Pinheiro-Costa, João, et al. “Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice.” Ophthalmologica, vol. 233, no. 3/4, June 2015, pp. 155–61. EBSCOhost, https://doi.org/10.1159/000381221.
APA
Pinheiro-Costa, J., Costa, J. M., Beato, J. N., Freitas-da-Costa, P., Brandão, E., Falcão, M. S., Falcão-Reis, F., & Carneiro, Â. M. (2015). Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice. Ophthalmologica, 233(3/4), 155–161. https://doi.org/10.1159/000381221
Chicago
Pinheiro-Costa, João, José M. Costa, João N. Beato, Paulo Freitas-da-Costa, Elisete Brandão, Manuel S. Falcão, Fernando Falcão-Reis, and Ângela M. Carneiro. 2015. “Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice.” Ophthalmologica 233 (3/4): 155–61. doi:10.1159/000381221.